Procyanidins-crosslinked aortic elastin scaffolds with distinctive anti-calcification and biological properties

Acta Biomaterialia

Volumn 16, Issue 1, 2015, Pages 81-93

  Wang, Xiaoya ^a,b   Zhai, Wanyin ^a   Wu, Chengtie ^a   Ma, Bing ^a   Zhang, Jiamin ^c   Zhang, Hongfeng ^b   Zhu, Ziyan ^c   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c Shanghai (Red Cross) Blood Center   (China)

Author keywords

Calcification; Crosslinking; Elastin; Procyanidins; Tissue engineering scaffold

Indexed keywords

BIOCOMPATIBILITY; BIOMINERALIZATION; BLOOD VESSELS; ELASTIN; FLAVONOIDS; GLYCOPROTEINS; PORE SIZE; SCAFFOLDS (BIOLOGY); STRUCTURE (COMPOSITION);

BIOLOGICAL PROPERTIES; CROSS-LINKING ABILITY; CROSSLINKED; DECELLULARIZED; EXTRACELLULAR MATRICES; LIFESPANS; POLYPHENOLS; PROCYANIDINS; TISSUE ENGINEERING APPLICATIONS; TISSUE ENGINEERING SCAFFOLD;

BONE;

ELASTASE; ELASTIN; GRAPE SEED EXTRACT; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; PROCYANIDIN; TUMOR NECROSIS FACTOR ALPHA; BIFLAVONOID; CATECHIN; CROSS LINKING REAGENT; GLUTARALDEHYDE; MINERAL; PANCREATIC ELASTASE; PROANTHOCYANIDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; BLOOD COMPATIBILITY; CALCIFICATION; CELL ADHESION; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MINERALIZATION; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; THROMBOCYTE ADHESION; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BLOOD CLOTTING; BONE MINERALIZATION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HEART VALVE; MACROPHAGE; METABOLISM; PIG; SPRAGUE DAWLEY RAT; STAINING; ULTRASTRUCTURE;

ANIMALS; AORTA; BIFLAVONOIDS; BLOOD COAGULATION; CALCIFICATION, PHYSIOLOGIC; CATECHIN; CELL ADHESION; CELL LINE; CROSS-LINKING REAGENTS; ELASTIN; GLUTARAL; HEART VALVES; HEMOLYSIS; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 12; MINERALS; PANCREATIC ELASTASE; PLATELET ADHESIVENESS; POROSITY; PROANTHOCYANIDINS; PROTEOLYSIS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; SUS SCROFA; TISSUE SCAFFOLDS;

EID: 84930664046     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.01.028     Document Type: Article

References (63)

1. Cornwell KG, Landsman A, James KS. Extracellular matrix biomaterials for soft tissue. Clin Podiatr Med Surg 2009;26:507-23.
2. Dolgin E. Taking tissue engineering to heart. Nat Med 2011;17:1032-5.
3. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21.
4. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MSB, et al. Tissue-engineered lungs for in vivo implantation. Science 2010;329:538-41.
5. Basu Joydeep, Ludlow John W. In: Wislet-Gendebien Sabine, editor. Tissue engineering of tubular and solid organs: an industry perspective, advances in regenerative medicine. InTech; 2011. ISBN:978-953-307-732-1, available from URL: http://www.intechopen.com/books/advances-in-regenerative-medicine/tissueengineering-f-tubular-and-solid-organs-an-industry-perspective.
6. Schmidt CE, Baier JM. Acellular vascular tissue: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-31.
7. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-80.
8. Daamen WF, Nillesen ST, Hafmans T, Veerkamp JH, van Luyn MJ, van Kuppevelt TH. Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 2005;26:81-92.
9. Nivison-Smith L, Rnjak J, Weiss AS. Synthetic human elastin microfibers-stable cross-linked tropoelastin and cell interactive constructs for tissue engineering applications. Acta Biomater 2009;6:354-9.
10. Leach JB, Wolinsky JB, Stone PJ, Wong JY. Crosslinked a-elastin biomaterials-towards a processable elastin mimetic scaffold. Acta Biomater 2005;1:155-64.
11. Kurane A, Simionescu DT, Vyavahare NR. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials 2007;28:2830-8.
12. Chow JP, Simionescu DT, Warner H, Wang B, Patnaik SS, Liao J, et al. Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials 2013;34:685-95.
13. Lu Q, Ganesan K, Simionescu DT, Vyavahare NR. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials 2004;25:5227-37.
14. Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol 2004;13:146-55.
15. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A 2003;66:93-102.
16. Perrotta I, Russo E, Camastra C, Filice G, Di Mizio G, Colosimo F, et al. New evidence for a critical role of elastin in calcification of native heart valve: immunohistochemical and ultrastructural study with literature review. Histopathology 2011;59:504-13.
17. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif 2005;23:64-71.
18. Fleisch H. Role of nucleation and inhibition in calcification. Clin Orthop 1964;22:170-80.
19. Fleisch H, Neuman WF. Mechanisms of calcification: role of collagen, polyphosphates and phosphatase. Am J Physiol 1961;200:1296-9.
20. Schiffmann E, Lavender DR, Miller EJ, Corcoran BA. Amino acids at the nucleating site in mineralizing elastic tissue. Calc Tiss Res 1969;3:125-35.
21. Chen NX, O'Neill KD, Chen X, Kiattisunthorn K, Gattone VH, Moe SM. Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 2011;34:211-9.
22. Tripi DR, Vyavahare NR. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves. J Biomater Appl 2014;28:757-66.
23. Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 2000;5:144-51.
24. Zhai W, Jia C, Zhao H, Xu Y. Procyanidins inhibit tumor angiogenesis by crosslinking extracellular matrix. Chin J Cancer Res 2011;23:99-106.
25. Rice-Evans C. Flavonoids and isoflavones (phytoestrogens): absorption, metabolism, and bioactivity. Free Radic Biol Med 2004;36:827-8.
26. Zhai W, Chang J, Lin K, Wang J, Zhao Q, Sun X. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 2006;27:3684-90.
27. Slusarewicz P, Zhu K, Hedman T. Kinetic characterization and comparison of various protein crosslinking reagents for matrix modification. J Mater Sci-Mater Med 2010;21:1175-81.
28. Zhai W, Chang J, Lu X, Wang Z. Procyanidins-crosslinked heart valve matrix: anticalcification effect. J Biomed Mater Res Part B: Appl Biomater 2009;90B:913-21.
29. Zhu Y, Hua Z, Song Y, Wu W, Zhou X, Zhou J, et al. Highly chemoselective esterification for the synthesis of monobutyl itaconate catalyzed by hierarchical porous zeolites. J Catal 2013;299:20-9.
30. Cheung DT, Tong D, Perelman N, Ertl D, Nimni ME. Mechanism of crosslinking of proteins by glutaraldehyde. IV: In vitro and in vivo stability of a crosslinked collagen matrix. Connect Tissue Res 1990;25:27-34.
31. Qin Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 2012;221:2-11.
32. Rieder E, Seebacher G, Kasimir M-T, Eichmair E, Winter B, Dekan B, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111:2792-7.
33. Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials 2004;25:3293-302.
34. Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 2006;27:3645-51.
35. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006;27:2907-10.
36. Johnson CM, Hanson MN, Helgeson SC. Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics. J Mol Cell Cardiol 1988;19:1185-93.
37. Simionescu DT, Lu Q, Song Y, Lee JS, Rosenbalm TN. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials 2006;27:702-13.
38. He Q, Zhang J, Chen F, Guo L, Zhu Z, Shi J. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 2010;31:7785-96.
39. Wu Y, Zhou Z, Meyerhoff ME. In vitro platelet adhesion on polymeric surfaces with varying fluxes of continuous nitric oxide release. J Biomed Mater Res 2007;81A:956-63.
40. He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010;31:1085-92.
41. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 2011;300:C210-20.
42. Dohmen PM, Costa F, Holinski S, Lopes SV, Yoshi S, Reichert LH, et al. Is there a possibility for a glutaraldehyde-free porcine heart valve to grow? Eur Surg Res 2006;38:54-61.
43. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002;11:457-62.
44. Leyh RG, Wilhelmi M, Rebe P, Fischer S, Kofidis T, Haverich A, et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg 2003;75:1457-63.
45. Bertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, Stevens MM. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater 2013;12:576-83.
46. Miller JD. Cardiovascular calcification: orbicular origins. Nat Mater 2013;12:476-8.
47. Kumata C, Mizobuchi M, Ogata H, et al. Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats. Ther Apher Dial 2011;15(Suppl. 1):18-22.
48. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998;102:1900-10.
49. Pai AS, Giachelli CM. Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol 2010;21:1637-40.
50. Maurice P, Blaise S, Gayral S, Debelle L, Laffargue M, Hornebeck W, et al. Elastin fragmentation and atherosclerosis progression: the elastokine concept. Trends Cardiovasc Med 2013;23:211-21.
51. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-b1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 2005;334:524-32.
52. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-a promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000;102:2636-42.
53. Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol 2012;8:529-43.
54. Zhang RY, Ma PX. Porous poly(L-lactic acid)/apatite compo-sites created by biomimetic process. J Biomed Mater Res 1999;45:285-93.
55. Kato R, Nakamura S, Katayama K, Yamashita K. Electrical polarization of plasma-spray-hydroxyapatite coatings for improvement of osteoconduction of implants. J Biomed Mater Res A 2005;74:652-8.
56. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001;294:1684-8.
57. Grant RA. Variation in the amino acid composition of aortic elastin from different species. Br J Exp Pathol 1966;47:163-7.
58. Hagerman AE, Butler LG. The specificity of proanthocyanidin-protein interactions. J Biol Chem 1981;256:4494-7.
59. Han B, Jaurequl J, Tang BW, Nimni ME. Proanthocyanidins: a natural crosslinking reagent for stabilizing collagen matrices. J Biomed Mater Res A 2003;65:118-24.
60. Urry DW, Long MM. Conformation of the repeat peptides of elastin in solution. Crit Rev Biochem 1976;4:1-45.
61. Galeone A, Paparella D, Colucci S, Grano M, Brunetti G. The role of TNF-a and TNF superfamily members in the pathogenesis of calcific aortic valvular disease. Sci World J 2013:875363. http://dx.doi.org/10.1155/2013/875363.
62. Owens NF, Gingell D, Trommler A. Cell adhesion to hydroxyl groups of a monolayer film. J Cell Sci 1988;91:269-79.
63. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007;82:864-73.